Levothyroxine Sample size and study design [Power / Sample Size]

posted by lakshmiprasad – India, 2018-04-14 14:55 (2201 d 05:41 ago) – Posting: # 18681
Views: 3,650

(edited by Ohlbe on 2018-04-16 10:31)

Dear All,

Good Evening,

Here I gone through the all Guidelines, I understood Now because NTI nature (https://www.fda.gov/downloads/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/abbreviatednewdrugapplicationandagenerics/ucm292676.pdf), We are going to do the Fully replicate.

Thank you very much for your guidence.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,651 registered users;
75 visitors (1 registered, 74 guests [including 7 identified bots]).
Forum time: 20:37 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5